MiNK Therapeutics, Inc.
INKTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How MiNK Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 5, 2026. The latest institutional report shown is dated Dec 31, 2025; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| HORIZON FINANCIAL SERVICES, LLC | 2025-12-31 | 160 | $1.78K | SEC filing |
| Longbow Finance SA | 2025-03-31 | 16,667 | Not shown | SEC filing |
| WELLS FARGO & COMPANY/MN | 2024-12-31 | 10,079 | Not shown | SEC filing |
| OSAIC HOLDINGS, INC. | 2024-12-31 | 1,431 | Not shown | SEC filing |
| STATE STREET CORP | 2024-12-31 | 25,515 | Not shown | SEC filing |
| Greenwich Wealth Management LLC | 2024-12-31 | 10,805 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2024-12-31 | 96,113 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2024-12-31 | 11,441 | Not shown | SEC filing |
| Game Plan Financial Advisors, LLC | 2024-12-31 | 170 | Not shown | SEC filing |
| Longbow Finance SA | 2024-12-31 | 166,666 | Not shown | SEC filing |
| JPMORGAN CHASE & CO | 2024-12-31 | 325 | Not shown | SEC filing |
| MORGAN STANLEY | 2024-12-31 | 334 | Not shown | SEC filing |
| BlackRock, Inc. | 2024-12-31 | 88,281 | Not shown | SEC filing |
| UBS Group AG | 2024-12-31 | 2,847 | Not shown | SEC filing |
| FMR LLC | 2024-12-31 | 1 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2024-12-31 | 5,401 | Not shown | SEC filing |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 2024-12-31 | 0 | $0 | SEC filing |
| VANGUARD GROUP INC | 2024-12-31 | 234,182 | Not shown | SEC filing |
- Each value is checked against MiNK Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 16 rows: no share price from within three months of their report dates is on file, so they could not be checked.
- 2 rows left out: the value per share they report is far from MiNK Therapeutics, Inc.'s share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so they may describe another security or share class.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security. Filers with a row left out above, or with no row above to check, are not listed.
- Longbow Finance SA: 166,666 shares reported 2024-12-31; 16,667 shares reported 2025-03-31.
- Longbow Finance SA: 166,666 shares reported 2024-09-30; 166,666 shares reported 2024-12-31.
- VANGUARD GROUP INC: 234,182 shares reported 2024-09-30; 234,182 shares reported 2024-12-31.
- CONCOURSE FINANCIAL GROUP SECURITIES, INC.: 0 shares reported 2024-09-30; 0 shares reported 2024-12-31.
- Tower Research Capital LLC (TRC): 4,027 shares reported 2024-09-30; 5,401 shares reported 2024-12-31.
- UBS Group AG: 6,212 shares reported 2024-09-30; 2,847 shares reported 2024-12-31.
- BlackRock, Inc.: 88,126 shares reported 2024-09-30; 88,281 shares reported 2024-12-31.
- Game Plan Financial Advisors, LLC: 170 shares reported 2024-09-30; 170 shares reported 2024-12-31.
- NORTHERN TRUST CORP: 11,073 shares reported 2024-09-30; 11,441 shares reported 2024-12-31.
- GEODE CAPITAL MANAGEMENT, LLC: 97,981 shares reported 2024-09-30; 96,113 shares reported 2024-12-31.
- Greenwich Wealth Management LLC: 10,805 shares reported 2024-09-30; 10,805 shares reported 2024-12-31.
- STATE STREET CORP: 25,515 shares reported 2024-09-30; 25,515 shares reported 2024-12-31.
Showing the 12 most recent filer reports.
14 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among MiNK Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2023-08-24 · AGENUS INC: Larger than 15 of the 16 other insider purchases of Common Stock on file. SEC filing
- 2023-05-05 · ARMEN GARO H: Larger than all 8 other insider sales of Common Stock on file. SEC filing
- 2021-10-19 · AGENUS INC: Larger than all 16 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-04 | Ryan Barbara · Director | Common Stock | S — Open market or private sale | −1,000 | 12.80 | SEC filing |
| 2026-06-04 | Ryan Barbara · Director | Common Stock | S — Open market or private sale | −500 | 12.68 | SEC filing |
| 2026-03-10 | Ryan Barbara · Director | Common Stock | S — Open market or private sale | −500 | 15.30 | SEC filing |
| 2026-03-10 | Ryan Barbara · Director | Common Stock | S — Open market or private sale | −300 | 15.28 | SEC filing |
| 2026-03-10 | Ryan Barbara · Director | Common Stock | S — Open market or private sale | −500 | 15.57 | SEC filing |
| 2026-03-09 | Ryan Barbara · Director | Common Stock | S — Open market or private sale | −200 | 10.17 | SEC filing |
| 2026-03-02 | Ryan Barbara · Director | Common Stock | S — Open market or private sale | −100 | 10.83 | SEC filing |
| 2026-02-27 | Ryan Barbara · Director | Common Stock | S — Open market or private sale | −400 | 10.86 | SEC filing |
Showing 8 of 19 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-01 | WIINBERG ULF · Director | Common Stock | A — Grant, award, or other acquisition | +1,131 | SEC filing |
| 2026-06-01 | Ryan Barbara · Director | Common Stock | A — Grant, award, or other acquisition | +1,434 | SEC filing |
| 2026-06-01 | Corvese Brian · Director | Common Stock | A — Grant, award, or other acquisition | +1,444 | SEC filing |
| 2026-06-01 | Holcomb John Bradley · Director | Common Stock | A — Grant, award, or other acquisition | +1,091 | SEC filing |
| 2026-06-01 | Behner Peter · Director | Common Stock | A — Grant, award, or other acquisition | +1,313 | SEC filing |
| 2026-03-02 | WIINBERG ULF · Director | Common Stock | A — Grant, award, or other acquisition | +1,285 | SEC filing |
| 2026-03-02 | Ryan Barbara · Director | Common Stock | A — Grant, award, or other acquisition | +1,629 | SEC filing |
| 2026-03-02 | Holcomb John Bradley · Director | Common Stock | A — Grant, award, or other acquisition | +1,239 | SEC filing |
Showing 8 of 21 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-10-11 | Buell Jennifer · Chief Executive Officer | Common Stock | J — Other acquisition or disposition | −695,750 | SEC filing |
| 2023-05-01 | AGENUS INC · 10% owner | Common Stock | J — Other acquisition or disposition | −4,988,273 | SEC filing |
| 2023-05-01 (amended) | AGENUS INC · 10% owner | Common Stock | J — Other acquisition or disposition | −5,006,397 | SEC filing |
Showing 3 of 3 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.